Scleral Buckling for Rhegmatogenous Retinal Detachment Associated with Pars Planitis.
Purpose. To evaluate the surgical outcome of scleral buckling (SB) in rhegmatogenous retinal detachment (RRD) patients associated with pars planitis. Methods. Retrospective review of RRD patients (32 eyes of pars planitis RRD and 180 eyes of primary RRD) who underwent SB. We compared primary and final anatomical success rates and visual outcomes between two groups. Results. Primary and final anatomical success were achieved in 25 (78.1%) and 31 (96.8%) eyes in the pars planitis RRD group and in 167 eyes (92.7%) and 176 eyes (97.7%) in primary RRD group, respectively. Both groups showed significant visual improvement (p < 0.001) and there were no significant differences in final visual acuity. Pars planitis RRD group was associated with higher rate of postoperative proliferative vitreoretinopathy (PVR) development (12.5% versus 2.8%, p = 0.031). Pars planitis and high myopia were significant preoperative risk factors and pseudophakia was borderline risk for primary anatomical failure after adjusting for various clinical factors. Conclusions. Pars planitis associated RRD showed inferior primary anatomical outcome after SB due to postoperative PVR development. However, final anatomical and visual outcomes were favorable. RRD cases associated with pars planitis, high myopia, and pseudophakia might benefit from different surgical approaches, such as combined vitrectomy and SB.
Department of Ophthalmology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.
Yong-Kyu
0000-0002-6850-1835
YK
Kim
Department of Ophthalmology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.
Wontae
0000-0002-5174-6334
W
Yoon
Jeonju Samsung Eye Clinic, Jeonju, Jeonrabuk-do, Republic of Korea.
Jae Kyoun
JK
Ahn
Department of Ophthalmology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.
Sung Pyo
0000-0002-6978-0311
SP
Park
Graefes Arch Clin Exp Ophthalmol. 2011 Aug;249(8):1129-36
21305315
Prog Retin Eye Res. 2016 Mar;51:125-55
26209346
Retina. 2005 Dec;25(8):957-64
16340523
Am J Ophthalmol. 2005 Sep;140(3):509-16
16196117
Indian J Ophthalmol. 2010 Jan-Feb;58(1):21-7
20029143
Ophthalmology. 2003 Feb;110(2):427-31
12578792
Invest Ophthalmol Vis Sci. 2010 Oct;51(10):4963-8
20554615
Acta Ophthalmol. 2013 May;91(3):282-7
22336429
Graefes Arch Clin Exp Ophthalmol. 1996 Jan;234(1):47-54
8750850
Retina. 2015 Dec;35(12):2552-7
26049617
Retina. 2002 Dec;22(6):719-24
12476097
Ophthalmology. 2005 Nov;112(11):1890-5
16271317
Ophthalmology. 2013 Sep;120(9):1804-8
23601799
Ophthalmology. 2006 Oct;113(10):1724-33
17011954
Am J Ophthalmol. 1976 Aug;82(2):277-82
949080
Ophthalmology. 1993 Jun;100(6):818-24; discussion 825
8510893
Arch Ophthalmol. 1985 Nov;103(11):1704-7
4062638
Ophthalmology. 2007 Dec;114(12):2142-54
18054633
Eye (Lond). 2007 Aug;21(8):1056-61
16691255
Curr Eye Res. 2012 Jun;37(6):492-9
22577767
Am J Ophthalmol. 2003 Jul;136(1):155-60
12834683
Retina. 2014 Oct;34(10):1945-51
24999720
Retina. 2011 Sep;31(8):1500-4
21606887
Ocul Immunol Inflamm. 2010 Jan;18(1):60-3
20128653
Arch Ophthalmol. 1968 Dec;80(6):747-53
5723314